Outpatient Treatment of Severe and Enduring Anorexia Nervosa
A Novel Outpatient Treatment for Patients With Severe and Enduring Anorexia Nervosa: Patient Characteristics, Treatment Goals, and Course of Treatment.
1 other identifier
observational
20
1 country
1
Brief Summary
Approximately 20-30 % of individuals with the eating disorder anorexia nervosa develop an enduring form of the illness. In this study a new treatment for patients with severe and enduring anorexia nervosa was described. The treatment is flexible and aims at enhancing quality of life. The participants consisted of all referrals resulting in an assessment or treatment period at the unit between May 2017 and May 2022. The study was a registry study. Information regarding patient characteristics, treatment goals, and the course of treatment was gathered from medical records.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started May 2017
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2022
CompletedFirst Submitted
Initial submission to the registry
January 11, 2023
CompletedFirst Posted
Study publicly available on registry
February 1, 2023
CompletedFebruary 1, 2023
January 1, 2023
5.1 years
January 11, 2023
January 23, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
How the treatment goals were met
Whether or not the patients' individual treatment goals, defined at the beginning of treatment, had been met, partly met, or not met at the end of treatment.
At the end of treatment, an average of 15.4 months
Interventions
A novel outpatient treatment of severe and enduring anorexia nervosa, aiming at enhancing quality of life and minimizing harm
Eligibility Criteria
Adult women with severe and enduring anorexia nervosa.
You may qualify if:
- Age ≥ 18 years
- A referral resulting in an assessment or treatment period at the unit for patients with severe and enduring anorexia nervosa at the HUS Helsinki University Hospital between May 2017 and May 2022.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
HUS Syömishäiriöyksikkö
Helsinki, PL 282, 00029 HUS, Finland
Related Publications (1)
Algars M, Oshukova S, Suokas J. A novel outpatient treatment model for patients with severe and enduring anorexia nervosa: an observational study of patient characteristics, treatment goals, and treatment course. J Eat Disord. 2023 Sep 6;11(1):150. doi: 10.1186/s40337-023-00877-x.
PMID: 37674214DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jaana Suokas, Ph.D.
HUS Helsinki Central Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Ph.D.
Study Record Dates
First Submitted
January 11, 2023
First Posted
February 1, 2023
Study Start
May 1, 2017
Primary Completion
May 31, 2022
Study Completion
May 31, 2022
Last Updated
February 1, 2023
Record last verified: 2023-01
Data Sharing
- IPD Sharing
- Will not share